The International Diabetes Federation (IDF) is an umbrella organisation of over 240 national diabetes associations in some 170 countries and territories. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950. IDF’s mission is to promote diabetes care, prevention and a cure worldwide. IDF is engaged in action to tackle diabetes from the local to the global level ― from programmes at community level to worldwide awareness and advocacy initiatives. The Federation’s activities aim to influence policy, increase public awareness and encourage health improvement, promote the exchange of high-quality information about diabetes, and provide education for people with diabetes and their healthcare providers. IDF is associated with the Department of Public Information of the United Nations and is in official relations with the World Health Organization (WHO). IDF is the global voice of diabetes worldwide and as such both represents people with diabetes and supports them through advocacy, educational tools, etc. IDF’s main role in the project is to lead the Patient Advisory Committee (PAC) alongside JDRF and NN, identifying and supporting people with diabetes as part of the PAC, liaising with other Work Packages to define the main tasks of the PAC, and support the PAC with communication and dissemination activities.

Dr Belma Malanda

Senior Manager, Policy and Programmes. Belma is a medical doctor with more than 14 years’ experience as Programme Manager, with more than five years working specifically on diabetes initiatives at the global level. He holds an MPH (on Health Systems Management and Policy) from the Institute of Tropical Medicine of Antwerp, Belgium and currently leads IDF’s the Policy and Programmes Department. Belma has extensive knowledge of global patients’ engagement initiatives and stakeholders in diabetes and NCDs and has been represented IDF at two Novartis initiatives: the “Global Patient Forum” and the “Diabetes and Obesity Patients Advisory Forum”, an advisory board to gain expert insight into issues surrounding the treatment of obesity, including supporting awareness, improving diagnosis, and furthering obesity research. He has also represented IDF and co-authored a paper on the SANOFI initiative to develop a “Center of Excellence for Patient Centricity” leading to a patient-centered transformation of the organisation. Dr Malanda has also contributed as a panellist to the 2017 Disease Experience Expert Panels in Copenhagen.

Lorenzo Piemonte

Communications Manager. Lorenzo has been with IDF for over ten years, fulfilling a number of functions within the External Relations department, including communications, public relations and stakeholder and event management. He is currently responsible for the organisation of the World Diabetes Day awareness campaign and manages all communications activities of IDF.

Phil Riley

Campaign Director. Phil oversees all external communication and campaigns, programmes and projects. Phil previously worked for the Federation from 2002 to 2010, leading IDF’s communications. During that time, he developed the World Diabetes Day campaign into a multi-stakeholder partnership with a dedicated project team. World Diabetes Day became an IDF flagship project and a United Nations observed day. Phil and his team built and executed the strategy to engage diverse stakeholder groups and individuals under a single unifying banner – diabetes blue circle concept, “Unite for Diabetes” – and established blue as the colour of diabetes. Before re-joining IDF in early 2018, Phil led PR and thought-leadership campaigns for US-based information management company Iron Mountain, where he became head of Global PR. He was responsible for designing and delivering integrated campaigns to create marketing content, raise brand awareness and generate marketing leads. The campaigns included research projects, content creation (white paper, blogs, viewpoint articles, infographics, sales enablement tools, etc.), as well as PR and social execution.